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http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2014, TaiwanAbstract The prevalence of diabetes around the world is increasing, and the complications
of diabetes are becoming worse so that the global burden of diabetes-related complications
is rising. The purpose of this study was to simulate the physiological condition of diabetes in
the human body by culturing human microvascular endothelial cell 1 (HMEC-1) cells in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 5.5mM glucose, 25mM glucose, and 50mM
glucose. The cell viability of HMEC-1 cells at the indicated glucose concentrations was
detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The
specific epithelial cell junction N-cadherin was measured by immunofluorescence. Further-
more, monocytic initiation of inflammatory reactions was studied by using Western blotting
and enzyme-linked immunosorbent assay. Based on our results, hyperglycemia treatment influ-
enced the distribution of N-cadherin-containing structures in HMEC-1 cells, whereas the
change of the inflammatory profiles in HMEC-1 cells was affected after their coculture with
the supernatant of diabetic THP-1 monocytes. In this study, we conclude that the removal
of endothelial N-cadherin caused by hyperglycemia (at the 25mM glucose and 50mM glucose
concentrations) may lead to endothelial dysfunction and subsequently endothelial cell death
in the late stage of diabetes. Furthermore, the loss of intercellular adhesion molecule 1 and
the upregulation of interleukin (IL)-1, IL-6, and tumor necrosis factor alpha mediated by dia-
betic monocytes showed altered interaction between the vascular endothelium and blood cells
in the diabetic microenvironment.
Copyright ª 2014, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.of Applied Science, National Hsinchu University of Education, Number 521, Nan-Da Road, Hsinchu,
e.edu.tw (H.-C. Chou).
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176 C.-L. Feng, H.-C. ChouIntroductionDiabetes mellitus (DM) is a group of metabolic diseases in
which a person has high blood sugar (i.e., hyperglycemia).
Hyperglycemia can cause a wide variety of serious compli-
cations in the human body, including micro- and macro-
vascular complications. The microangiopathy leads to
retinopathy, nephropathy, neuropathy, and diabetic foot
pathology, whereas macroangiopathy is associated with the
progression of atherosclerosis, sclerosis, myocardial infarc-
tion, and stroke. In recent years, many research groups have
proven that the development of these diabetic complica-
tions is dependent on the integrity and function of endo-
thelial cells.1e3 Because endothelial dysfunction is
characterized as a major cardiovascular risk factor and
inflammation is associated with endothelial dysfunction,1e3
it is important to understand the crosstalk between endo-
thelial dysfunction and inflammation in diabetes.Materials and methods
Cell lines and cell culture
Human microvascular endothelial cell 1 (HMEC)-1 and THP-
1, a human monocyte, were used in this experiment. Both
cell types were grown in Dulbecco’s modified Eagle’s me-
dium (DMEM), which contained 10% fetal bovine serum, L-
glutamine (2mM), streptomycin (100 mg/mL), and penicillin
(100 IU/mL) (all items were obtained from Gibco-Invitrogen
Corp., Loughborough, Leicestershire, UK). Both cell types
were cultured at different glucose concentrations: 5.5mM,
25mM, and 50mM. The 25mM glucose concentration cor-
responded to the plasma glucose levels in diabetic patients
at 2 hours after a meal and the 50mM glucose concentra-
tion corresponded to the glucose level in uncontrolled
diabetic patients. The 5.5mM glucose concentration was
used as the control condition and corresponded to the
fasting plasma glucose level in nondiabetic people. We also
collected the THP-1 supernatant after treating it at the
indicated glucose concentrations; we then used the su-
pernatant to treat HMEC-1 cells for 4 days, 8 days, and 12
days. The cells were subcultured every 2 days, which was
followed by the replacement of the THP-1 supernatant.
The cells were incubated at 37C in a humidified 5% carbon
dioxide (CO2) incubator.
1Figure 1 The effect of different glucose concentrations on
cell viability in humanmicrovascular endothelial cell 1 (HMEC-1)
cells. A MTT assay was used to detect the effect of different
glucose concentrations (5.5mM glucose, 25mM glucose, and
50mM glucose) on the viability of HMEC-1 cells. MTT Z 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.MTT assay
The method of detecting cell viability was similar to the
method used in our previous work.1 We seeded 8000 cells
per well in a 96-well plate, and then incubated them for 24
hours at concentrations of 5.5mM glucose, 25mM glucose,
and 50mM glucose. After 24 hours, we removed the medium
and added 50 mL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) working solution to
cells in each well. They were further incubated for 4 hours
at 37C. The supernatant was carefully removed and 100 ml
dimethyl sulfoxide (DMSO) was added to each well. Absor-
bance of the samples was measured at a wavelength of
545 nm.Immunofluorescence
The immunofluorecence method in this study was similar to
themethodused inourprevious research.1,4Weseeded75,000
cells per well in a 24-well plate with 12-mm diameter glasses,
and then incubated them for 24 hours at the concentration of
5.5mM glucose, 25mM glucose, and 50mM glucose. The next
day,we removed themediumand the cellswere twicewashed
with phosphate-buffered saline (PBS). The cells were fixed
with paraformaldehyde for 20 minutes. We then used 0.1%
Triton X-100 (SIGMA-ALDRICH, St. Louis, USA) to permeabilize
the cell membranes, and used bovine serum albumin (BSA) for
1 hour to block the cells. After that, the cells underwent im-
munostaining for N-cadherin for 1 hour. N-cadherin is a
cellecell adhesion protein. The purpose was to look at the
epithelial tissues, especially epithelial specific cell-cell junc-
tions. A corresponding secondary antibody was thereafter
used for immunostaining for 1 hour. The 12-mm diameter
glasses were fixed on slide glass with antifade reagent, and
fluorescence image analysis was conducted.
Western blotting
The method was similar to the method used in our previous
work.1 The cells were trypsinized, mixed with 1X NP40
buffer, and centrifuged at 13,000  g for 30 minutes at 4C.
The supernatant was collected and Coomassie Protein Assay
Reagent (Bio-Rad, Hercules, USA) was used to quantify the
cell lysates. The supernatant was mixed with a sample
buffer and heated at 95C for 5 minutes. The final sample
was stored at 20C until further use. Proteins were
separated on 12% acrylamide gels and then transferred to a
membrane. After blocking in 5% BSA, the membrane was
incubated with intercellular adhesion molecule 1 (ICAM-1)
and b-tubulin. Bound antibodies were detected using horse
radish peroxidase (HRP)-conjugated secondary antibodies
and an electrochemiluminescence solution.
Enzyme-linked immunosorbent assay
The method of enzyme-linked immunosorbent assay
(ELISA) was similar to the method used in our previous
Figure 2 Immunostaining of HMEC-1 cells treated with different concentrations of glucose. Cells on the cover slips have been
fixed and stained for N-cadherin (green). Compared to 5.5mM glucose concentration, high glucose concentrations (i.e., 25mM and
50mM) induce the disassembly of cell junction N-cadherin. HMEC Z human microvascular endothelial cell.
Diabetic monocyte and microvascular endothelial cell 177work.1 First, the coated supernatant was placed into mul-
tiple 96-well ELISA plates overnight at 4C. Second, the
supernatant was removed and blocked with 5% BSA at 37C
for 1 hour. The blocking buffer was then removed, the
primary antibodies (which in this study were IL-1, IL-6, and
TNF-a) were added and incubated overnight at 4C. Third,
the primary antibodies were removed, and the HRP-
conjugated secondary antibodies were added and then
incubated for 2 hours at 37C. Tetramethylbenzidine (TMB)
solution was added for another 30 minutes. Sulfuric acid
(H2SO4) was used to terminate the reaction, and the
absorbance of the samples was measured at a wavelength
of 450 nm.Figure 3 The expression level of intercellular adhesion molecule
(HMEC-1) cells treated with the conditioned medium of glucose-s
glucose concentrations, the cells were lysed, and then analyzed b
(which is the loading control). (A) The Western blot shows the same
The Western blot shows a time-dependent decrease of ICAM-1 in T
concentrations for 4 days, 8 days, and 12 days. (C) The quantificatStatistical analysis
The data are presented as the mean  standard error of the
mean. Statistical analyses were performed using the two-
tailed Student t test by SigmaPlot 12.5 software (San Jose,
California, USA). A value of p < 0.05 was considered sta-
tistically significant.
Results
MTT assay cell viability
Cell viability of HMEC-1 cultured at different glucose con-
centrations (5.5mM, 25mM, and 50mM) was measured by1 (ICAM-1) protein in human microvascular endothelial cell 1
timulated THP-1 cells. Under the treatment of the indicated
y Western blotting for the expression of ICAM-1 and b-tubulin
expression levels of ICAM-1 in the untreated HMEC-1 cells. (B)
HP-1 supernatant-treated HMEC-1 cells at the various glucose
ion of ICAM-1 expression using densitometry.
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among these cells; however, cell viability declined as the
glucose concentrations increased.Immunofluorescent staining of N-cadherin in HMEC-
1 cells
The adhesion molecule N-cadherin supports contacts be-
tween endothelial cells. Our results showed that hypergly-
cemia compromises the structural integrity of N-cadherin in
HMECs through distorting and disintegrating the cell junc-
tions (indicated by yellow arrows in Fig. 2).ICAM-1 protein expression levels in HMEC-1 cells
ICAM-1, vascular cell adhesion molecule 1 (VCAM-1), and E-
selectin proteins have important roles in maintaining intact
endothelial cells. By using Western blotting, we further
detected the expression of the aforementioned proteins in
HMEC-1 cells treated for 4 days, 8 days, and 12 days in the
culture supernatant from the glucose-stimulated THP-1
cells. There were no significant changes in the level
of VCAM-1 and E-selectin (data not shown), and the
downregulation of ICAM-1 was time-dependent after 4Figure 4 Enzyme-linked immunosorbent assay (ELISA) analysis of
in human microvascular endothelial cell 1 (HMEC-1) cells treated w
The ELISA analysis against IL-1, IL-6, and TNF-a was measured in
supernatant, the gray bar indicates the HMEC-1 supernatant, a
culture supernatant-treated HMEC-1 cell. (A) The supernatant fro
for 4 days. (B) The supernatant from the aforementioned cells was i
the aforementioned cells was incubated in 5.5mM glucose for 12 d
incubated in 25mM glucose for 4 days, 8 days, and 12 days, respecti
incubated in 50mM glucose for 4 days, 8 days, and 12 days, respecdays of glucose treatment by the supernatant of the
hyperglycemia-treated THP-1 cells (Fig. 3).
ELISA analysis of IL-1, IL-6, and TNF-a
Using ELISA, the effect of the THP-1 cell supernatant on
inducing inflammatory responses was detected in HMEC-1
cells under each of the glucose concentrations for 4 days, 8
days, and 12 days. The data showed that THP-1 supernatant
results in the increased secretion of IL-1 on treating HMEC-1
cells with 5.5mM glucose for 4 days, 25mM glucose for 8
days, or 50mM for 4 days. Furthermore, the THP-1 cell su-
pernatant results in the increased secretion of IL-6 on
treating HMEC-1 cells with 5.5mM glucose for 4 days or
25mM glucose for 8 days. In addition, the THP-1 cell su-
pernatant results in the increased secretion of TNF-a on
treating HMEC-1 cells with 5.5mM glucose for 8 days, 25mM
glucose for 8 days, or 50mM glucose for 12 days (Fig. 4).
Discussion
Vascular endothelial cells provide a physical barrier to con-
trol the passage of plasma and circulating cells to underlying
tissues. This specialized function is lost or impaired in early
alterations of inflammation and diabetes. Endothelialinterleukin (IL)-1, IL-6, and tumor necrosis factor alpha (TNF-a)
ith the conditioned medium of glucose-stimulated THP-1 cells.
the treated HMEC-1 cells. The white bar indicates the THP-1
nd the black bar indicates the supernatant from the THP-1
m the aforementioned cells was incubated in 5.5mM glucose
ncubated in 5.5mM glucose for 8 days. (C) The supernatant from
ays. (DeF) The supernatant from the aforementioned cells was
vely. (GeI) The supernatant from the aforementioned cells was
tively. * Indicates statistical significance at p < 0.05.
Diabetic monocyte and microvascular endothelial cell 179permeability is primarily regulated by the dynamics of the
cellecell adherens junctions, which includes the family of
cadherins, catenins, and adhesion molecules.
According to our results, hyperglycemia treatment
influenced the distribution of N-cadherin-containing struc-
tures in HMEC-1 cells (Fig. 2). The expression level of ICAM-
1 is decreased in HMEC-1 cells treated with the conditioned
medium of glucose-stimulated THP-1 cells (Fig. 3).
Furthermore, the changes in the inflammatory profiles of
HMEC-1 cells were affected after coculturing the superna-
tant of diabetic THP-1 monocytes with HMEC-1 cells, as
Figs. 3 and 4 show. Because cadherin proteins reportedly
have an important role in inducing inflammation,5 it is
interesting to observe the sequential changes of N-cadherin
and inflammatory cytokines (IL-1, IL-6, and TNF-a) after
glucose treatment. It is likely that abnormal levels of
glucose activate monocytes and increase the secretion of
inflammatory cytokines, thereby enhancing the risk of
impaired innate immunity and the development of endo-
thelial dysfunction and diabetic complications. The disor-
ganized distribution of N-cadherin can be regarded as an
early hyperglycemia sign in the chronic disease diabetes. It
would furthermore be useful to optimize the coculture
system of monocytes and endothelial cells to determine the
scenario of the diabetic microenvironment.Conflicts of interest
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